Immunovant, Inc. (IMVT) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Offerpad to move stock listing from NYSE to Nasdaq
- Macquarie Starts L&T Financial Holdings (LTFH:IN) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
